TriMas Co. (NASDAQ:TRS) Director Shawn Sedaghat Buys 249,597 Shares of Stock

TriMas Co. (NASDAQ:TRSGet Free Report) Director Shawn Sedaghat acquired 249,597 shares of the stock in a transaction dated Friday, March 7th. The shares were bought at an average cost of $23.83 per share, for a total transaction of $5,947,896.51. Following the completion of the transaction, the director now owns 346,825 shares in the company, valued at approximately $8,264,839.75. This represents a 256.71 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website.

Shawn Sedaghat also recently made the following trade(s):

  • On Monday, March 10th, Shawn Sedaghat acquired 554,149 shares of TriMas stock. The shares were bought at an average cost of $24.07 per share, for a total transaction of $13,338,366.43.

TriMas Stock Down 0.7 %

Shares of TRS opened at $23.98 on Wednesday. The business’s 50 day moving average is $23.56 and its 200 day moving average is $25.07. The company has a market capitalization of $973.18 million, a PE ratio of 37.47 and a beta of 0.65. TriMas Co. has a 12-month low of $19.33 and a 12-month high of $28.51. The company has a current ratio of 2.83, a quick ratio of 1.44 and a debt-to-equity ratio of 0.60.

TriMas Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 28th were paid a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a yield of 0.67%. The ex-dividend date of this dividend was Friday, February 28th. TriMas’s dividend payout ratio (DPR) is presently 27.12%.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on TRS. BWS Financial reissued a “buy” rating and set a $40.00 target price on shares of TriMas in a research note on Friday, February 28th. StockNews.com raised TriMas from a “sell” rating to a “hold” rating in a research note on Wednesday, November 13th.

Read Our Latest Report on TriMas

Institutional Trading of TriMas

A number of large investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in TriMas by 2.2% in the 4th quarter. Vanguard Group Inc. now owns 3,895,946 shares of the industrial products company’s stock worth $95,801,000 after acquiring an additional 82,068 shares during the last quarter. Bank of America Corp DE increased its stake in TriMas by 127.3% in the 4th quarter. Bank of America Corp DE now owns 3,513,638 shares of the industrial products company’s stock worth $86,400,000 after acquiring an additional 1,967,738 shares during the last quarter. Wellington Management Group LLP increased its stake in TriMas by 10.7% in the 3rd quarter. Wellington Management Group LLP now owns 2,619,359 shares of the industrial products company’s stock worth $66,872,000 after acquiring an additional 252,537 shares during the last quarter. Bellecapital International Ltd. bought a new stake in TriMas in the 4th quarter worth approximately $29,160,000. Finally, Medina Value Partners LLC increased its stake in TriMas by 2.9% in the 4th quarter. Medina Value Partners LLC now owns 1,034,882 shares of the industrial products company’s stock worth $25,448,000 after acquiring an additional 28,851 shares during the last quarter. Institutional investors own 99.42% of the company’s stock.

About TriMas

(Get Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Read More

Insider Buying and Selling by Quarter for TriMas (NASDAQ:TRS)

Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.